Remission of diabetes mellitus type 2 with severe hyperglycemia after Exenatide treatment.
Al-Jebawi
Ahmed F
AF
Indiana University School of Medicine, Indianapolis, IN, USA. aaljebaw@iupui.edu
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000077270:Exenatide; D005260:Female; D006801:Humans; D008687:Metformin / Q000008:administration & dosage; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy; D010455:Peptides / Q000627:therapeutic use*; D012074:Remission Induction; D000077154:Rosiglitazone; D013453:Sulfonylurea Compounds / Q000008:administration & dosage; D045162:Thiazolidinediones / Q000008:administration & dosage; D014688:Venoms / Q000627:therapeutic use*; D015431:Weight Loss
D010455:Peptides; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D014688:Venoms; D000077154:Rosiglitazone; C057619:glimepiride; D008687:Metformin; D000077270:Exenatide